B D Klassen1, R M Sadler. 1. Division of Neurology, Dalhousie University, Halifax, Nova Scotia, Canada.
Abstract
PURPOSE: To describe the induction of hypersensitivity to one antiepileptic drug (AED) by a second AED. METHODS: Case report and review of the relevant literature. RESULTS: A patient is reported who was treated with phenytoin (PHT) for 6 months without adverse effect, but developed a hypersensitivity reaction with rash, fever, elevated liver enzymes, lymphadenopathy, and colitis 6 weeks after the introduction of carbamazepine (CBZ). PHT and CBZ were discontinued. Seizures continued despite treatment with valproic acid and clobazam. A decision was made to cautiously reintroduce PHT. Diffuse skin rash and pharyngitis appeared after two doses of PHT. CONCLUSIONS: The AED hypersensitivity syndrome has been thought to occur as a consequence of preexisting pharmacogenetic and immunologic abnormalities. Our case demonstrates induction of hypersensitivity to an AED that had been formerly well tolerated, after a hypersensitivity reaction to another AED. This is distinct from simple cross-reactivity between one or more drugs. Such induction of hypersensitivity with AEDs has not been previously described.
PURPOSE: To describe the induction of hypersensitivity to one antiepileptic drug (AED) by a second AED. METHODS: Case report and review of the relevant literature. RESULTS: A patient is reported who was treated with phenytoin (PHT) for 6 months without adverse effect, but developed a hypersensitivity reaction with rash, fever, elevated liver enzymes, lymphadenopathy, and colitis 6 weeks after the introduction of carbamazepine (CBZ). PHT and CBZ were discontinued. Seizures continued despite treatment with valproic acid and clobazam. A decision was made to cautiously reintroduce PHT. Diffuse skin rash and pharyngitis appeared after two doses of PHT. CONCLUSIONS: The AED hypersensitivity syndrome has been thought to occur as a consequence of preexisting pharmacogenetic and immunologic abnormalities. Our case demonstrates induction of hypersensitivity to an AED that had been formerly well tolerated, after a hypersensitivity reaction to another AED. This is distinct from simple cross-reactivity between one or more drugs. Such induction of hypersensitivity with AEDs has not been previously described.
Authors: Kim B Handoko; Eugène P van Puijenbroek; Annemarie H Bijl; Walter A J J Hermens; Jeannette E F Zwart-van Rijkom; Yechiel A Hekster; Toine C G Egberts Journal: Drug Saf Date: 2008 Impact factor: 5.606